Semax Review: Benefits, Human Studies, Dosage and Side Effects
Semax is a synthetic seven-amino-acid peptide developed from a fragment of adrenocorticotropic hormone, or ACTH. Human studies have examined it during stroke rehabilitation and in brain-imaging experiments. Animal studies have measured brain-derived neurotrophic factor (BDNF), learning-related pathways and responses to brain injury.[1][2][3]
This review covers those measured effects, the preparations used in studies, reported safety issues and the difference between Semax and Selank. Mind Lab Pro is the separate nootropic supplement alternative featured below.
What Is Semax?
Semax has the amino-acid sequence Met-Glu-His-Phe-Pro-Gly-Pro, abbreviated MEHFPGP. Its first four residues correspond to ACTH(4-7), followed by a Pro-Gly-Pro extension. It is also described in the literature as ACTH(4-7)PGP.[1]
| Property | Details |
|---|---|
| Compound | Semax |
| Peptide sequence | Met-Glu-His-Phe-Pro-Gly-Pro (MEHFPGP) |
| Research shorthand | ACTH(4-7)PGP |
| Formula | C37H51N9O10S |
| Molecular weight | 813.9 g/mol |
| PubChem CID | 9811102 |
| Human study route discussed | Intranasal |

The peptide has a molecular formula of C37H51N9O10S and molecular weight of approximately 813.9 g/mol. The unmodified sequence, an acetate salt and terminally modified derivatives need to be identified separately when comparing products.[1]
How Does Semax Work?
Semax research has focused on neurotrophic signaling, gene expression and the response to ischemic injury. Several experiments measured BDNF, a protein involved in neuronal survival and synaptic function.
BDNF in the Rat Brain
A 2006 study found specific, reversible Semax binding in membranes isolated from rat basal forebrain. After intranasal administration at 50 or 250 micrograms/kg, BDNF protein levels increased in the basal forebrain at three hours. The same increase was not found in the cerebellum.[2]
A separate study measured BDNF and nerve growth factor gene expression at multiple times after Semax administration. The direction of change depended on the brain region and time point: expression initially decreased in the hippocampus while increasing in the frontal cortex. Later measurements showed a different pattern.[4]
Enkephalin-Related Research
A laboratory study tested Semax and Selank against enzymes in human serum that break down leu-enkephalin. Semax inhibited this breakdown with an IC50 of 10 micromolar; Selank had an IC50 of 20 micromolar. Several five-amino-acid fragments also inhibited the enzymes.[5]
Semax Benefits: Human Study Results
The clearest human data concern functional recovery after stroke and changes in resting-state brain activity. These studies measured different outcomes and used different participant groups.
| Study | Preparation and participants | Measured result |
|---|---|---|
| Stroke rehabilitation | 110 patients; two 10-day courses | Higher BDNF and improved Barthel outcomes in Semax-treated groups [3] |
| Resting-state MRI | 24 healthy adults; 14 Semax, 10 placebo | Larger rostral default-mode network component after 1% intranasal Semax [6] |
| Connectivity comparison | 52 healthy adults; Semax, Selank and placebo | Changes in right-amygdala connectivity [7] |
Semax During Stroke Rehabilitation
A 2018 study evaluated 110 patients after ischemic stroke. Participants were grouped by early or late rehabilitation and by whether they received Semax. The reported regimen consisted of two ten-day courses at 6,000 micrograms daily, with a twenty-day interval.[3]
The researchers measured plasma BDNF, motor performance and the Barthel Index, which assesses independence in everyday activities. Semax-treated groups showed increased plasma BDNF, and the authors reported faster improvement and a better final Barthel score. Early rehabilitation was also associated with improved motor performance.[3]
Brain Imaging in Healthy Adults
A placebo comparison included 24 healthy adults: 14 received intranasal 1% Semax and 10 received placebo. Resting-state MRI scans were performed before administration and at five and twenty minutes. The Semax group showed a larger rostral component of the default mode network, involving the medial frontal cortex.[6]
A later 52-person experiment compared Semax, Selank and placebo. It identified differences in functional connectivity between the right amygdala and parts of the temporal cortex.[7]
Semax and Depression Research
A 2024 study gave male Sprague-Dawley rats Semax or Melanotan II during chronic unpredictable stress. Daily intraperitoneal administration at 60 nmol/kg attenuated or reversed four stress-related changes: loss of sucrose preference, reduced weight gain, adrenal enlargement and lower hippocampal BDNF. Neither peptide changed immobility in the forced-swim test.[8]
Semax Dosage and Preparation
The 6 mg daily regimen above came from a stroke-rehabilitation study. Other human experiments used a 1% intranasal preparation. A standardized dose for cognitive enhancement in healthy adults has not been established.[3][6]
The FDA review found that the human literature it assessed concerned intranasal administration. The proposed compounded preparations also included subcutaneous injection.[9]
Semax Side Effects and Safety
The FDA's 2026 briefing identified insufficient clinical information to characterize the safety profile of Semax free base or acetate. It highlighted potential immunogenicity associated with aggregation and peptide-related impurities, and the absence of safety data for the proposed subcutaneous route. [9]
Semax vs. Selank
Semax uses the sequence MEHFPGP, while Selank uses TKPRPGP. Their first four amino acids differ and both end in Pro-Gly-Pro. Semax's human literature includes stroke rehabilitation; Selank's includes comparisons with benzodiazepines in anxiety-related disorders.[1][7][10]
Our N-acetyl Selank amidate review explains the additional terminal modifications used in that derivative. Its chemical identity differs from the unmodified Selank used in the clinical comparisons.
Semax User Experiences
In the original "Semax 2 Week Experience" post, u/SuperCoolCas described improved verbal fluency and recall alongside emotional blunting and worse sleep. The author also identified other factors that could have contributed to the sleep changes.[11]
A contrasting first-week account reported no noticeable improvement in energy, focus or motivation. Responses included both similarly unresponsive users and people describing subtle improvements in focus.[12]

Where to Buy Semax
Compare the full peptide name, preparation and batch documentation. Semax, Semax acetate and N-acetyl Semax amidate are different label descriptions. Mind Lab Pro is the separate cognitive-supplement alternative featured above; the nootropics catalog below lists individual research products and their current stock status.
Semax FAQ
These questions cover concentration labels, peptide chemistry and other details beyond the study outcomes above.
Has Semax Been Studied as an ADHD Treatment?
The FDA's 2026 review found no supporting clinical literature for Semax as an ADHD treatment. It identified a hypothesis article proposing possible use in ADHD and Rett syndrome. ADHD was therefore excluded from the agency's evaluation of therapeutic uses.[9]
Is Semax a Steroid?
What Is the Difference Between 0.1% and 1% Semax?
A 1% Semax solution has ten times the concentration of a 0.1% solution when both percentages use the same weight-per-volume convention. Those concentrations correspond to 10 mg/mL and 1 mg/mL, respectively. The amount in a drop or spray also depends on the volume delivered by the device.
How Should Laboratory Semax Be Stored?
Laboratory Semax should be stored according to the specific product's stability instructions. Cayman lists -20°C and at least four years of stability for its solid Semax research material. Its data sheet recommends keeping aqueous solutions for no longer than one day.[13]
Is Semax Acetate the Same as N-Acetyl Semax?
Semax Review: Conclusion
Semax has human findings in stroke rehabilitation and functional brain imaging, alongside animal research on BDNF and injury-response pathways. The stroke-rehabilitation study reported improved functional recovery; the healthy-volunteer studies measured changes in brain-network activity. The FDA review identified unresolved safety questions for the proposed compounded preparations.[3][6][9]
References
- PubChem. Semax. CID 9811102. Accessed November 7, 2026.
- Dolotov OV, Karpenko EA, Seredenina TS, Inozemtseva LS, Levitskaya NG, Zolotarev YA, Kamensky AA, Grivennikov IA, Engele J, Myasoedov NF. Semax, an analogue of adrenocorticotropin (4-10), binds specifically and increases levels of brain-derived neurotrophic factor protein in rat basal forebrain. Journal of neurochemistry. 2006;97 Suppl 1:82-86.
- Gusev EI, Martynov MY, Kostenko EV, Petrova LV, Bobyreva SN. [The efficacy of semax in the tretament of patients at different stages of ischemic stroke]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2018;118:61-68.
- Shadrina M, Kolomin T, Agapova T, Agniullin Y, Shram S, Slominsky P, Lymborska S, Myasoedov N. Comparison of the temporary dynamics of NGF and BDNF gene expression in rat hippocampus, frontal cortex, and retina under Semax action. Journal of molecular neuroscience : MN. 2010;41:30-35.
- Kost NV, Sokolov OIu, Gabaeva MV, Grivennikov IA, Andreeva LA, Miasoedov NF, Zozulia AA. [Semax and selank inhibit the enkephalin-degrading enzymes from human serum]]. Bioorganicheskaia khimiia. 2001;27:180-183.
- Lebedeva IS, Panikratova YR, Sokolov OY, Kupriyanov DA, Rumshiskaya AD, Kost NV, Myasoedov NF. Effects of Semax on the Default Mode Network of the Brain. Bulletin of experimental biology and medicine. 2018;165:653-656.
- Panikratova YR, Lebedeva IS, Sokolov OY, Rumshiskaya AD, Kupriyanov DA, Kost NV, Myasoedov NF. Functional Connectomic Approach to Studying Selank and Semax Effects. Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections. 2020;490:9-11.
- Inozemtseva LS, Yatsenko KA, Glazova NY, Kamensky AA, Myasoedov NF, Levitskaya NG, Grivennikov IA, Dolotov OV. Antidepressant-like and antistress effects of the ACTH(4-10) synthetic analogs Semax and Melanotan II on male rats in a model of chronic unpredictable stress. European journal of pharmacology. 2024;984:177068.
- FDA. Semax-related bulk drug substances: Pharmacy Compounding Advisory Committee briefing. July 23-24, 2026.
- Zozulia AA, Neznamov GG, Siuniakov TS, Kost NV, Gabaeva MV, Sokolov OIu, Serebriakova EV, Siranchieva OA, Andriushenko AV, Telesheva ES, Siuniakov SA, Smulevich AB, Miasoedov NF, Seredenin SB. [Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2008;108:38-48.
- Reddit. u/SuperCoolCas. Semax 2 Week Experience.
- Reddit. u/acn97. Semax Experience - makes me wonder.
- Cayman Chemical. Semax, item 27719: product information.
- Shevchenko KV, Nagaev IY, Andreeva LA, Shevchenko VP, Myasoedov NF. Stability of Semax acetyl to proteolysis in various biological media. Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections. 2013;449:110-112.
- Bachem. Frequently asked questions: peptide salts.
